Cargando…

Generalizability of machine learning methods in detecting adverse drug events from clinical narratives in electronic medical records

We assessed the generalizability of machine learning methods using natural language processing (NLP) techniques to detect adverse drug events (ADEs) from clinical narratives in electronic medical records (EMRs). We constructed a new corpus correlating drugs with adverse drug events using 1,394 clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zitu, Md Muntasir, Zhang, Shijun, Owen, Dwight H., Chiang, Chienwei, Li, Lang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368879/ https://www.ncbi.nlm.nih.gov/pubmed/37502211 http://dx.doi.org/10.3389/fphar.2023.1218679

Ejemplares similares

Accuracy and generalizability of using automated methods for identifying adverse events from electronic health record data: a validation study protocol
por: Rochefort, Christian M., et al.
Publicado: (2017)

PhenoDEF: a corpus for annotating sentences with information of phenotype definitions in biomedical literature
por: Binkheder, Samar, et al.
Publicado: (2022)

Correction: PhenoDEF: a corpus for annotating sentences with information of phenotype definitions in biomedical literature
por: Binkheder, Samar, et al.
Publicado: (2022)

Approach to machine learning for extraction of real-world data variables from electronic health records
por: Adamson, Blythe, et al.
Publicado: (2023)

Predicting Adverse Drug Events in Chinese Pediatric Inpatients With the Associated Risk Factors: A Machine Learning Study
por: Yu, Ze, et al.
Publicado: (2021)

Temporal Generalizability of Machine Learning Models for Predicting Postoperative Delirium Using Electronic Health Record Data: Model Development and Validation Study
por: Matsumoto, Koutarou, et al.
Publicado: (2023)

Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies
por: Lee, Shu-Ping, et al.
Publicado: (2019)

Adverse events recording in electronic health record systems in primary care
por: de Hoon, Sabine E. M., et al.
Publicado: (2017)

758. High-Throughput Mining of Electronic Medical Records Using Generalizable Autonomous Scripts
por: Rochat, Ryan H, et al.
Publicado: (2019)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
por: Su, Si, et al.
Publicado: (2023)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
por: Katsuno, Hayato, et al.
Publicado: (2021)

Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System
por: Guo, Haoning, et al.
Publicado: (2022)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
por: Ma, Pan, et al.
Publicado: (2022)

Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
por: Guo, Qiang, et al.
Publicado: (2022)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate
por: Chen, Xiaoyi, et al.
Publicado: (2018)

A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning
por: Zhang, Ni, et al.
Publicado: (2022)

On the generalizability of resting-state fMRI machine learning classifiers
por: Huf, Wolfgang, et al.
Publicado: (2014)

Dataset’s chemical diversity limits the generalizability of machine learning predictions
por: Glavatskikh, Marta, et al.
Publicado: (2019)

Generalizable Machine Learning in Neuroscience Using Graph Neural Networks
por: Wang, Paul Y., et al.
Publicado: (2021)

Development of scalable and generalizable machine learned force field for polymers
por: Mohanty, Shaswat, et al.
Publicado: (2023)

Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
por: Guo, Haoning, et al.
Publicado: (2022)

Variation in adverse drug events of opioids in the United States
por: Liu, Edward Y., et al.
Publicado: (2023)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
por: Jiao, Xue-Feng, et al.
Publicado: (2023)

Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies
por: Schutijser, Bernadette Clara Francisca Maria, et al.
Publicado: (2020)

Current landscape and tailored management of immune-related adverse events
por: Liu, Wenhui, et al.
Publicado: (2023)

Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system
por: Jeong, Eugene, et al.
Publicado: (2022)

A generalizable and accessible approach to machine learning with global satellite imagery
por: Rolf, Esther, et al.
Publicado: (2021)

Generalizability of Machine Learning Models: Quantitative Evaluation of Three Methodological Pitfalls
por: Maleki, Farhad, et al.
Publicado: (2022)

Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System
por: Yang, Renjun, et al.
Publicado: (2022)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bai, Xiaoyin, et al.
Publicado: (2021)

Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system
por: Onda, Kenji, et al.
Publicado: (2023)

Immune-related adverse events of biological immunotherapies used in COVID-19
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
por: Wakabayashi, Tomohito, et al.
Publicado: (2022)

A novel method of adverse event detection can accurately identify venous thromboembolisms (VTEs) from narrative electronic health record data
por: Rochefort, Christian M, et al.
Publicado: (2015)

Predictive modeling of structured electronic health records for adverse drug event detection
por: Zhao, Jing, et al.
Publicado: (2015)

Electronic Medical Record–Based Machine Learning Approach to Predict the Risk of 30-Day Adverse Cardiac Events After Invasive Coronary Treatment: Machine Learning Model Development and Validation
por: Kwon, Osung, et al.
Publicado: (2022)

Hospitalizations Due to Adverse Drug Events in the Elderly—A Retrospective Register Study
por: Laatikainen, Outi, et al.
Publicado: (2016)

Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine
por: Ngai, Jamie, et al.
Publicado: (2022)

Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
por: Tian, Xiaojiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08vf4eg670dkka41b3idfdkd6e